
Sign up to save your podcasts
Or


Dive into the transformative world of bead-based assays with Sebastian Giehring, CEO and founder of PAIA Biotech, where high-throughput screening meets cutting-edge biotechnological advancements.
Join us as we chat with Sebastian, a seasoned scientist and entrepreneur who has revolutionized the workflow of high-throughput screening of titer, glycosylation, and aggregation with innovative bead-based assays.
Key Takeaways:
Tune in to uncover how these insights can transform your lab's capabilities and drive groundbreaking discoveries!
Connect with Sebastian Giehring:
LinkedIn: https://www.linkedin.com/in/sebastian-giehring-6ba1992
PAIA Biotech: https://www.paiabio.com
Next Steps:
Book a free assessment to help you get started with the design of your next experiment at https://bruehlmann-consulting.com
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at [email protected]
Support the show
Ready to revolutionize your lab work? Join us as we dive deep into bead-based assays with Sebastian Giehring, CEO and founder of PAIA Biotech.
Discover how these tiny beads are making a massive impact on biotech research and development — for titer, glycan, and aggreation screening — and how this developability screening platform can enhance your antibody discovery, antibody engineering and lead optimization.
In this episode, you’ll learn:
Tune in to uncover how these assays can transform your biotech research and push the boundaries of what's possible!
Connect with Sebastian Giehring:
LinkedIn: https://www.linkedin.com/in/sebastian-giehring-6ba1992
PAIA Biotech: https://www.paiabio.com
Next Steps:
Book a free assessment to help you get started with the design of your next experiment at https://bruehlmann-consulting.com
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at [email protected]
Support the show
How do small biotech companies make strategic decisions with limited resources? This episode dives deep into the art of prioritization and outsourcing to achieve success.
Join us as we speak with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, a seasoned biotech scientist with years of experience in both large and small biotech companies. Mark shares his invaluable insights on navigating the complexities of bioprocess development and outsourcing.
In this episode, we explore:
Connect with Mark Melville:
LinkedIn: https://www.linkedin.com/in/mark-melville-a9a43b2
Next Steps:
Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
Are you navigating the complex world of bioprocess CMC development and manufacturing in a small biotech company?
Our latest episode is a must-listen! Join us as we sit down with Mark Melville, Vice President of CMC, Biologics at Cullinan Therapeutics, who shares invaluable insights on overcoming the unique challenges faced by small biotech firms.
In this episode, we explore:
Tune in to discover how mastering these areas can help your small biotech thrive and stay ahead in a competitive market.
Don't miss this opportunity to gain practical advice and turn your challenges into advantages!
Connect with Mark Melville:
LinkedIn: https://www.linkedin.com/in/mark-melville-a9a43b2
Next Steps:
Wondering how to develop biologics with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
In this insightful episode, we explore the cutting-edge field of glycoengineering and its transformative impact on biopharmaceutical drug design. Join us as we chat with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, to uncover the nuances of chemoenzymatic glycogen engineering and its potential to revolutionize therapeutics.
Key Takeaways:
Don't miss this deep dive into how glycoanalytics is paving the way for more effective and personalized biopharmaceutical drugs. Tune in to understand the future of drug design and the exciting possibilities it holds.
Connect with Róisín O’Flaherty:
LinkedIn: https://www.linkedin.com/in/roisin-o-flaherty-a67a2b8a
Twitter: https://x.com/irishglycogirl
Next Steps:
Book a free assessment to help you get started with glycoanalytics and glycoengineering at https://bruehlmann-consulting.com
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at [email protected]
Support the show
Uncover the hidden science behind creating safer, more effective biological drugs! Dive into glycoanalytics and glycoengineering, the secret weapons revolutionizing biopharma.
Join us as we talk with Róisín O’Flaherty, Assistant Professor in the Department of Chemistry at Maynooth University, who breaks down the complexities of glycosylation and its pivotal role in drug development.
Key Takeaways:
Tune in to explore how glycoanalytics is driving the next generation of safer, more effective biopharmaceuticals!
Connect with Róisín O’Flaherty:
LinkedIn: https://www.linkedin.com/in/roisin-o-flaherty-a67a2b8a
Twitter: https://x.com/irishglycogirl
Next Steps:
Book a free assessment to help you get started with glycoanalytics and glycoengineering at https://bruehlmann-consulting.com
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at [email protected]
Support the show
Join us as we explore the pivotal role of process mapping in biotech knowledge management. Our guest, Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, shares invaluable insights into leveraging technology to streamline operations.
Key Insights:
Join us as Irwin uncovers actionable steps to enhance efficiency and innovation in biotech through strategic process mapping.
Connect with Irwin Hirsh:
LinkedIn: https://www.linkedin.com/in/ishirsh
Q-Specialists AB: https://www.qspecialists.com
Next Steps:
Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Free 5-day email course, The CMC Failure Chain: the five recurring CMC mistakes that put your promising program at risk → Get it here
Support the show
Want to turn your biotech chaos into streamlined success? Learn from expert Irwin Hirsh, a seasoned biotech consultant concentrating on enhancing business efficiency and effectiveness, on how process mapping can transform your knowledge management and elevate your business performance.
Key Takeaways:
Tune in to uncover practical strategies that can transform your knowledge management practices and drive your biotech endeavors to new heights.
Connect with Irwin Hirsh:
LinkedIn: https://www.linkedin.com/in/ishirsh
Q-Specialists AB: https://www.qspecialists.com
Next Steps:
Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
Get ready to dive into the fascinating world of cryopreservation!
In this episode, we welcome Mark Davison, an experienced entrepreneur and CEO of Grant Instruments, leaders in laboratory equipment, to explore the intricate science of freezing and thawing cells.
Mark brings his wealth of experience to demystify this crucial process, revealing how cutting-edge technology ensures precision and reliability in preserving biological samples.
Key Takeaways:
Tune in for an insightful conversation that blends technical expertise with practical advice, perfect for scientists and entrepreneurs alike!
Connect with Mark Davison:
LinkedIn: https://www.linkedin.com/in/markdavison100
The Big Experiment podcast: https://thebigexperiment.buzzsprout.com
Grant Instruments: https://www.grantinstruments.com
Next Steps:
Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Support the show
Picture a world where we can freeze cells and bring them back to life perfectly intact.
In this episode, we're joined by Mark Davison, a leading expert in cryopreservation and CEO of Grant Instruments to uncover the intricate science of freezing and thawing cells. From basic principles to advanced techniques, we delve into how cryopreservation is revolutionizing biotechnology and cell therapies.
Key Takeaways:
Tune in to explore how cryopreservation is shaping the future of biotech!
Connect with Mark Davison:
LinkedIn: https://www.linkedin.com/in/markdavison100
The Big Experiment podcast: https://thebigexperiment.buzzsprout.com
Grant Instruments: https://www.grantinstruments.com
Next Steps:
Wondering how to develop biologics and cell & gene therapies with peace of mind? Schedule your free assessment to propel your success: https://bruehlmann-consulting.com/assessment
Develop biologics better, faster, at a fraction of the cost with our Fractional CTO services. Curious? DM us at https://bruehlmann-consulting.com
Free 5-day email course, The CMC Failure Chain: the five recurring CMC mistakes that put your promising program at risk → Get it here
Support the show
From the publisher's feed
The go-to CMC and biomanufacturing podcast for bioprocess development scientists and CMC leaders scaling biologics into regulatory-ready therapies with less trial and…
Practical, execution-focused, and strategic guidance on CMC development, tech transfer, scale-up, GMP readiness, CDMO partnerships, and manufacturing economics for biologics, cell and gene therapies, cultivated meat, and biomaterials.
Hosted by Dr. David Brühlmann, CMC strategist, former Bioprocess Innovation Manager at Merck, PhD in glycoengineering, and close to 20 years of biomanufacturing experience. Smart Biotech Scientist delivers actionable insights for the people doing the hard work of turning promising molecules into scalable, regulatory-ready therapies.
This podcast is for you if:
What you will learn:
CMC strategy and regulatory planning, bioprocess scale-up from lab to clinical and commercial manufacturing, cell culture process development and media optimization, technology transfer best practices, CDMO selection and partnership management, hybrid modeling, manufacturing economics, continuous manufacturing, digitization, and Industry 4.0 in biopharma.
Top 10 life sciences podcast with 200+ episodes and guests from Merck, FUJIFILM Irvine Scientific, Cytiva, KBI Biopharma, Eppendorf, and biotech innovators worldwide.
New episodes released weekly. Subscribe and join 400+ biotech leaders already using these insights to accelerate development, reduce manufacturing costs, and de-risk scale-up.
Next Steps:
Get the 5-day CMC email course: https://smartbiotechscientist.com/#cmc
Visit the website: https://smartbiotechscientist.com
Email us: [email protected]

8,394 Listeners

467 Listeners

85 Listeners

35 Listeners

29,181 Listeners